Tranexamic acid for reducing mortality in emergency and urgent surgery

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 1, 2013, Pages

  Perel, Pablo ^a   Ker, Katharine ^a   Morales Uribe, Carlos Hernando ^b   Roberts, Ian ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSIDAD DE ANTIOQUIA   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

BLOOD TRANSFUSION; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; DEEP VEIN THROMBOSIS; DRUG EFFECT; EMERGENCY SURGERY; EVIDENCE BASED MEDICINE; HEART INFARCTION; HUMAN; LUNG EMBOLISM; MORTALITY; OPERATIVE BLOOD LOSS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REOPERATION; REVIEW; SEIZURE; SYSTEMATIC REVIEW; THROMBOEMBOLISM; UNCERTAINTY; ADULT; BLEEDING; EMERGENCY; META ANALYSIS; UTILIZATION REVIEW;

ADULT; ANTIFIBRINOLYTIC AGENTS; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; EMERGENCIES; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRANEXAMIC ACID;

MLCS; MLOWN;

EID: 84874815566     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD010245.pub2     Document Type: Review

References (18)

1. Hemsinli D, Pulathan Z, Altun G, Yasar Guven K, Civelek A. The effect of tranexamic acid and desmopressin acetate infusion on coagulation parameters in patients operated under dual antiplatelet therapy. 8th International Congress of Update in Cardiology and Cardiovascular Surgery Antalya Turkey. Carden Jennings Publishing Co. Ltd, 2012; Vol. 15:S21-2.
2. Moghaddam MJ, Darabi E, Sheikholeslamy F. Effect of tranexamic acid in decreasing need to transfusion in hip fracture surgery. European Journal of Anaesthesiology 2011;28:89.
3. Pfizer. Prospective randomised phase IV open label comparative study of tranexamic acid plus standard care versus standard care for the reduction of blood loss in subjects undergoing surgery for long bone fracture. PhRMA Web Synopsis. Protocol B1461005 2011.
4. Sadeghi M, Mehr-Aein A. Does a single bolus dose of tranexamic acid reduce blood loss and transfusion requirements during hip fracture surgery? A prospective randomized double blind study in 67 patients. Acta Medica Iranica 2007;45(6):437-42.
5. Zufferey PJ, Miquet M, Quenet S, Martin P, Adam P, Albadalejo P, et al.Tranexamic acid in hip fracture surgery: a randomized controlled trial. British Journal of Anaesthesia 2010;104(1):23-30.
6. Bainbridge D, Martin J, Arango M, Cheng D. Perioperative and anaesthetic-related mortality in developed and developing countries: a systematic review and meta-analysis. Lancet 2012;380:1075-81.
7. The CRASH-2 Collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010;376:23-32.
8. Debas HT, Gosselin R, McCord C, Thind A. Surgery. Disease control priorities in developing countries. 2nd Edition. New York: Oxford University Press, 2006:1245-60.
9. Goodnough LT, Shander A. Risk and complications of blood transfusions: optimizing outcomes for patients with chemotherapy induced anemia. Advanced Studies in Medicine 2008;8(10):357-62.
10. Henry David A, Carless Paul A, Moxey Annette J, O'Connell D, Stokes Barrie J, Fergusson Dean A, et al.Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd, 2011, issue 3. [DOI: 10.1002/14651858.CD001886.pub4;: CD001886]
11. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). Available from www.cochrane-handbook.org. The Cochrane Collaboration, 2011.
12. Karkouti K, Wijeysundera DN, Yau TM, Beattie WS, Abdelnaem E, McCluskey SA, et al.The independent association of massive blood loss with mortality in cardiac surgery. Transfusion 2004;44(10):1453-62.
13. Klein HG, Spahn DR, Carson JL. Red blood cell transfusion in clinical practice. Lancet 2007;370:415-26.
14. Mannucci PM. Prevention and Treatmentof Major Blood Loss. New England Journal of Medicine 2007;356:2301-11.
15. Okamoto S, Hijikata-Okunomiya A, Wanaka K, Okada Y, Okamoto U. Enzyme controlling medicines: introduction. Seminars in thrombosis and hemostasis 1997;23:493-501.
16. Pearse RM, Harrison DA, James P, Watson D, Hinds C, Rhodes A, Grounds RM, Bennett ED. Identification and characterisation of the high-risk surgical population in the United Kingdom. Critical Care 2006;10:R81.
17. Weiser TG, Regenbogen SE, Thompson KD, Haynes AB, Lipsitz SR, Berry WR, Gawande AA. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet 2008;372(9633):139-44.
18. Perel P, Ker K, Morales UCH, Roberts I. Tranexamic acid for reducing mortality in emergency and urgent surgery. Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd, 2012, issue 11. [DOI: 10.1002/14651858.CD010245;: CD010245]